Emosis

Menu
  • Emosis
  • Solution
    • Seeking a serial killer in patient’s blood
    • Induced diseases
    • Our answer: cells at center stage
    • Flow cytometry: the other colors of blood
  • Products
    • Hit Confirm®
    • ClotSeek®
    • Plateletogram®
    • OnkoClot®
    • Aplis®
  • About
    • Who we are
    • Our team
    • What drives us
    • Where we are
  • Investors
    • Well-balanced shareholding structure
    • A rich ecosystem
    • Market outlook
    • Regulatory
  • News
  • Contact us

Emosis

  • Emosis
  • Solution
    • Seeking a serial killer in patient’s blood
    • Induced diseases
    • Our answer: cells at center stage
    • Flow cytometry: the other colors of blood
  • Products
    • Hit Confirm®
    • ClotSeek®
    • Plateletogram®
    • OnkoClot®
    • Aplis®
  • About
    • Who we are
    • Our team
    • What drives us
    • Where we are
  • Investors
    • Well-balanced shareholding structure
    • A rich ecosystem
    • Market outlook
    • Regulatory
  • News
  • Contact us

 

left4 news

EMOSIS announces ISO 9001:2015 and ISO 13485:2016 certifications

Strasbourg, France –November 14th, 2017

Emosis, a medical device company specializing in cell-based hemostasis and thrombosis diagnostics, is glad to announce that the company has recently obtained its ISO 9001:2015 and ISO 13485:2016 certificates.

Download

Tweet

© 2021 Emosis Diagnostics

  • Sitemap

Website by e-novea web agency